Evidence map›Paper›PMID 27917075›Full record

ArticleGastroenterology & hepatology2016

Management of

Layth S Al-Jashaami, Herbert L DuPont

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology & hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  4. Article
  5. Beyond Antibiotics: What the Future Holds.Antibiotics (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Correlating Antibiotic-Induced Dysbiosis toACS infectious diseases · 2023
    Article
  11. Biofilm Formation ofMicroorganisms · 2023
    Review
  12. The Urgent Threat ofBiomedicines · 2023
    Review
  13. Article
  14. The role of the gut microbiome in colonization resistance and recurrentTherapeutic advances in gastroenterology · 2022
    Review
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Bezlotoxumab (Zinplava) forP & T : a peer-reviewed journal for formulary management · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Layth S Al-JashaamiDr Al-Jashaami is a clinical assistant professor at the University of Arizona College of Medicine in Phoenix, Arizona. Dr DuPont is a professor and director of the Center for Infectious Diseases at the University of Texas Houston School of Public Health and the McGovern Medical School in Houston, Texas; president of the Kelsey Research Foundation in Houston, Texas; and a clinical professor at Baylor College of Medicine in Houston, Texas.
Herbert L DuPontDr Al-Jashaami is a clinical assistant professor at the University of Arizona College of Medicine in Phoenix, Arizona. Dr DuPont is a professor and director of the Center for Infectious Diseases at the University of Texas Houston School of Public Health and the McGovern Medical School in Houston, Texas; president of the Kelsey Research Foundation in Houston, Texas; and a clinical professor at Baylor College of Medicine in Houston, Texas.
University of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the discovery of

Indexed as

Antibiotic-associated diarrheaClostridium difficile infectionfecal microbiota transplantationmonoclonal antibodiesoral vancomycin

Identifiers

PMID27917075
PMCPMC5114503
OpenAlexW2577581975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.